In today’s competitive research environment, success depends on having the most up-to-date information. Scientists and business leaders working in genome sequencing rely on In Sequence to bring them exclusive, in-depth business, technology, and regulatory news on:
Next-generation sequencing technology
Funding for genome sequencing
Advances in Sanger sequencing
Sequencing in clinical research
Status of major sequencing projects and centers
In addition, every online subscription to In Sequence provides this important coverage:
Updates on patents, licensing, and IP litigation
Technology transfer and translational research
Funding reports, including research grants and venture capital
Exclusive interviews with business, technology, and research leaders
New product launches and upgrades
Summaries of relevant research papers
Management news: hirings, firings, and promotions
Every subscriber receives a weekly email bulletin containing clickable links to the latest headlines plus unlimited full-text access to the entire online archive of In Sequence.
*12-week introductory offer for new subscribers only. Customers who have previously ordered an introductory subscription within the past 12 months will be invoiced the difference of the full-year rate of $985.